We are live on ! Find out more
ANIX icon

Anixa Biosciences
ANIX

18 hedge funds and large institutions have $2.23M invested in Anixa Biosciences in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more capital invested

Capital invested by funds: $1.59M → $2.23M (+$630K)

1.69% more ownership

Funds ownership: 4.01% → 5.7% (+1.7%)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

10% less funds holding

Funds holding: 20 → 18 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$929K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$138K
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$117K
4
Northern Trust
Northern Trust
Illinois
+$11.9K
5
Bank of America
Bank of America
North Carolina
+$2.7K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$162K
2
TSS
Two Sigma Securities
New York
-$117K
3
WS
Wedbush Securities
California
-$34K
4
CAM
Concorde Asset Management
Michigan
-$5.19K
5
Morgan Stanley
Morgan Stanley
New York
-$5.07K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.73M +$929K +358,320 +96%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$206K +$138K +53,251 +155%
Bank of New York Mellon
3
Bank of New York Mellon
New York
$107K +$117K +45,249 New
Northern Trust
4
Northern Trust
Illinois
$48K +$11.9K +4,599 +29%
DIA
5
Denver Investment Advisors
Colorado
$41K – – –
TSS
6
Two Sigma Securities
New York
$28K -$117K -45,116 -79%
CAM
7
Concorde Asset Management
Michigan
$27K -$5.19K -2,000 -15%
UBS Group
8
UBS Group
Switzerland
$16K -$2.12K -817 -10%
BlackRock
9
BlackRock
New York
$11K – – –
Bank of America
10
Bank of America
North Carolina
$3K +$2.7K +1,040 +1,300%
Morgan Stanley
11
Morgan Stanley
New York
$2K -$5.07K -1,955 -65%
JP Morgan Chase
12
JP Morgan Chase
New York
$2K – – –
Wells Fargo
13
Wells Fargo
California
$2K – – –
Deutsche Bank
14
Deutsche Bank
Germany
$2K +$2.6K +1,002 New
EWM
15
Evercore Wealth Management
New York
$1K – – –
SWM
16
SeaCrest Wealth Management
New York
$1K +$1.3K +500 New
VF
17
Virtu Financial
New York
– -$162K -61,536 Closed
WS
18
Wedbush Securities
California
– -$34K -13,000 Closed
IA
19
IFP Advisors
Florida
– -$3K -1,000 Closed
TDC
20
Thompson Davis & Co
Virginia
– -$1K -250 Closed

ANIX Hedge Fund Activity: Q4 2017 in Review

18 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q4 2017, worth a combined $2.23M — up 39% from $1.59M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ANIX and 3 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 4 added.

The largest buyer was Vanguard Group, adding an estimated $929K. The largest seller was Virtu Financial, exiting entirely with an estimated $162K sold.

  • 18 institutional investors held Anixa Biosciences (ANIX) as of Q4 2017, down from 20 in Q3 2017.
  • Funds reported $2.23M of Anixa Biosciences stock for Q4 2017, up 39% quarter-over-quarter.
  • 3 funds opened new Anixa Biosciences positions in Q4 2017 and 5 closed out, a net change of -2 holders.
  • The largest Anixa Biosciences buyer in Q4 2017 was Vanguard Group, an estimated $929K added.
  • The largest Anixa Biosciences seller in Q4 2017 was Virtu Financial, an estimated $162K sold.

Based on aggregated 13F filings for Q4 2017.